ePrints

Rosiglitazone was noninferior to metformin plus sulfonylurea for CV events but increased risk for HF and fractures in type 2 diabetes

Lookup NU author(s): Emeritus Professor Philip Home

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Home PD, Pocock SJ, Beck-Nielsen H

Publication type: Review

Publication status: Published

Journal: Annals of Internal Medicine

Year: 2009

Volume: 151

Issue: 8

Pages: JC4-8

ISSN (print): 0003-4819

ISSN (electronic): 1539-3704

Publisher: AMER COLL PHYSICIANS

URL: http://www.annals.org/content/151/8/JC4-8.full.pdf+html

DOI: ARTN JC4-8

Share